( 2002 ) Peptide-based cancer vaccines . Seminars in Oncology , 29 , 494 – 502 .Machiel J P,van Baren N,Marchand M.Peptide-based cancer vaccines. Seminars in Oncology . 2002J.-P. Machiels, N. van Baren, and M. Marchand, "Peptide-based cancer vaccines," Seminars in Oncology, vol....
Peptide-based vaccines for cancer: are we choosing the right peptides? Recently, immunotherapy has emerged as a treatment strategy in the adjuvant setting of breast cancer. In this review, monoclonal antibodies in passive and ... Vasso,Apostolopoulos - 《Expert Review of Vaccines》 被引量: 32...
Peptide-based vaccines for cancer: are we choosing the right peptides? Recently, immunotherapy has emerged as a treatment strategy in the adjuvant setting of breast cancer. In this review, monoclonal antibodies in passive and ... Vasso,Apostolopoulos - 《Expert Review of Vaccines》 被引量: 32...
Drug Discov Today Ingale S, Wolfert MA, Buskas T, Boons GJ (2009) 18(17–18):807–817 Increasing the antigenicity of synthetic tumor- Khong H, Overwijk WW (2016) Adjuvants for peptide- associated carbohydrate antigens by targeting Toll-like based cancer vaccines. J Immunother ...
摘要: Examines the clinical efficacy of peptide-based vaccination for cancer patients. Classification of tumor-associated antigens recognized by T cells; Approaches to increase immunogenicity of human tumor-associated antigen peptides; Advantages of using peptide-based vaccines....
Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer Vaccines. Immunotherapies have emerged as a revolutionary modality for cancer treatment, and a variety of immune-based approaches are currently being investigated in... Amar,Patel,Lawrence,... - 《Oncology》 被...
Vaccination produces profound and long lasting modifications in the adaptive immune system comprising T and B cells. Vaccines are curative not mere palliative remedies and thus vaccination is the most efficient method to prevent and to lesser extent treat infectious diseases, cancer, and allergy conditi...
epitope peptides incorporating promiscuous T-cell epitopes that afford the possibility of generating an enduring immune response, eliciting protein-reactive high-affinity anti-peptide antibodies as potential vaccines and peptide mimics that act as antagonists to receptor signaling that drive cancer metastasis...
CANCER vaccinesBackground: Tumor antigen peptide vaccines have shown remarkable efficacy, safety, and reliability in recent studies. However, the screening process for immunopotent antigenic peptides is cumbersome, limiting their widespread application. Identifying neoantigen peptide...
Here we have reported a novel strategy to increase the efficiency of peptide-based cancer vaccines, using a dual approach of targeting the vaccine construct to XCR1+ cDC1 and enhancing antigen entry into the cross-presentation pathway through the use of an endosomal escape CPP. We find that th...